Asturpharma Overview

  • Year Founded
  • 1985

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 85

Employees

  • Latest Deal Type
  • M&A

Asturpharma General Information

Description

Manufacturer of raw materials and intermediates intended for application in the pharmaceutical market. The company's products include antibiotics, penicillin derivatives, cardiocirculatory, antineoplasics and antiarthritic

Contact Information

Website
www.asturpharma.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Parent Company
Grupo Enerthi
Primary Office
  • O'Donnell 34 3º
  • Izquierda
  • Madrid
  • Spain
+34 914 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Asturpharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 23-Oct-2010 Completed Generating Revenue
2. Bankruptcy: Admin/Reorg Completed Bankruptcy: Admin/Reorg
1. Early Stage VC Completed Startup
To view Asturpharma’s complete valuation and funding history, request access »

Asturpharma Patents

  • 59

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Asturpharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2321153-A1 Intermediate for the synthesis of piperacilina (machine-translation by google translate, not legally binding) Active 11-Oct-2007 0
ES-2321153-B1 Intermediate for the synthesis of piperacilina. Inactive 11-Oct-2007
EP-1431287-A1 Optically pure paroxetine precursos Inactive 18-Dec-2002 0000000000 0
ES-2211327-A1 Optically pure paroxetine precursos Active 18-Dec-2002 0000000000 0
ES-2211327-B1 Optically pure paroxetine precursors. Inactive 18-Dec-2002 C12P41/004
To view Asturpharma’s complete patent history, request access »

Asturpharma Executive Team (2)

Name Title Board Seat Contact Info
Peter Ortiz Commercial Director
You’re viewing 1 of 2 executive team members. Get the full list »

Asturpharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Asturpharma Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Sociedad Regional de Promoción del Principado de Asturias Corporation Minority 000 0000 000000 0
To view Asturpharma’s complete investors history, request access »

Ready to get started?

Request a free trial